{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:28:48Z","timestamp":1790015328964,"version":"4.0.1"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Context<\/jats:title><jats:p>Although renal long-term complications are acknowledged in chronic hypoparathyroidism (HPT), standardized investigations are scarce.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To systematically investigate renal complications and their predictors in hypoparathyroid patients compared to matched individuals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Prospective observational study in 161 patients with chronic HPT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients received renal ultrasound, clinical and laboratory assessments. An individual 1:3 matching with participants from the German population-based Study of Health in Pomerania was performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 161 patients (92% postoperative HPT), prevalence of eGFR &amp;lt;60ml\/min\/1.73m<jats:sup>2<\/jats:sup> was 21%, hypercalciuria 41%. Compared to healthy individuals, HPT patients had a significantly lower eGFR (74.2 vs. 95.7 ml\/min\/1.73m\u00b2, p&amp;lt;0.01). Renal ultrasound revealed calcifications in 10% (nephrocalcinosis in 7% and calculi in 3%). Patients with renal calcifications had higher levels of 24-hour urine calcium excretion (8.34 vs. 5.08 mmol\/d, p=0.02), spot urine calcium excretion (4.57 vs. 2.01 mmol\/L, p=0.01) and urine calcium-to-creatinine ratio (0.25 vs. 0.16, p&amp;lt;0.01) than patients without calcifications. Albumin-corrected calcium, phosphate, calcium-phosphate product, 25-hydroxyvitamin D in serum, eGFR, daily calcium intake or disease duration were not significantly different between these two groups. Including patients receiving rhPTH therapy, a lower serum phosphate concentration (odds ratio 1.364 [95% confidence interval (CI) 1.049-1.776], p&amp;lt;0.05) and a longer disease duration of HPT (odds ratio 1.063 [95% CI 1.021-1.106], p&amp;lt;0.01) were significant predictors for renal calcifications. Excluding patients receiving rhPTH therapy, a higher 24-hour urine calcium excretion (odds ratio 1.215 [95% CI 1.058-1.396], p&amp;lt;0.01) was a significant predictor for renal calcifications but not serum magnesium or disease duration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Prevalence of impaired renal function among patients with chronic HPT is increased and independent from visible renal calcifications. Depending on exclusion of patients with rhPTH therapy, regression analysis revealed disease duration and serum phosphate or disease duration and 24-hour urinary calcium excretion as predictors for renal calcifications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clin Trials Identifier<\/jats:title><jats:p>NCT05585593<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1244647","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T06:31:06Z","timestamp":1698993066000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Renal complications in chronic hypoparathyroidism \u2013 a systematic cross-sectional assessment"],"prefix":"10.3389","volume":"14","author":[{"given":"Karen","family":"Gronemeyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmina Teresa","family":"Fuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Hermes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Plass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Cathrin","family":"Koschker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Hannemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"V\u00f6lzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Hahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1056\/NEJMcp0803050","article-title":"Hypoparathyroidism","volume":"359","author":"Shoback","year":"2008","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/clinem\/dgaa113","article-title":"Hypoparathyroidism","volume":"105","author":"Bilezikian","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3907","article-title":"Management of hypoparathyroidism: summary statement and guidelines","volume":"101","author":"Brandi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3910","article-title":"Management of hypoparathyroidism: Present and future","volume":"101","author":"Bilezikian","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1460215","article-title":"Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D","volume":"146","author":"Arlt","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1477","article-title":"Epidemiology and health-related quality of life in hypoparathyroidism in Norway","volume":"101","author":"Astor","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1979","article-title":"Cardiovascular and renal complications to postsurgical hypoparathyroidism: A Danish nationwide controlled historic follow-up study","volume":"28","author":"Underbjerg","year":"2013","journal-title":"J Bone Miner Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2501","article-title":"The epidemiology of nonsurgical hypoparathyroidism in Denmark: A nationwide case finding study","volume":"30","author":"Underbjerg","year":"2015","journal-title":"J Bone Miner Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-018-0857-5","article-title":"Efficacy and safety of long-term management of patients with chronic post-surgical hypoparathyroidism","volume":"41","author":"Meola","year":"2018","journal-title":"J Endocrinol Invest."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-118181","article-title":"Long-term follow-up and treatment of postoperative permanent hypoparathyroidism in patients with medullary thyroid carcinoma: differences in complete and partial disease","volume":"48","author":"Leidig-Bruckner","year":"2016","journal-title":"Horm Metab Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02629-w","article-title":"Canadian national hypoparathyroidism registry: an overview of hypoparathyroidism in Canada","volume":"72","author":"Khan","year":"2021","journal-title":"Endocrine."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14470","article-title":"Determinants of hypercalciuria and renal calcifications in chronic hypoparathyroidism: A cross-sectional study","volume":"95","author":"Ridder","year":"2021","journal-title":"Clin Endocrinol (Oxf)."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz319","article-title":"Nephrocalcinosis, renal dysfunction, and calculi in patients with primary hypoparathyroidism on long-term conventional therapy","volume":"105","author":"Saha","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/jendso\/bvaa181","article-title":"Hipopara-red, real life experience in 322 patients with hypoparathyroidism","volume":"5","author":"Zanchetta","year":"2021","journal-title":"J Endocr Soc"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3368","article-title":"Long-term complications in patients with hypoparathyroidism evaluated by biochemical findings: A case-control study","volume":"33","author":"Underbjerg","year":"2018","journal-title":"J Bone Miner Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1590\/2359-3997000000221","article-title":"Hypoparathyroidism and pseudohypoparathyroidism: etiology, laboratory features and complications","volume":"60","author":"Lopes","year":"2016","journal-title":"Arch Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0580","article-title":"Long-term complications in patients with chronic hypoparathyroidism: a cross-sectional study","volume":"180","author":"David","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01686-2","article-title":"Renal complications and quality of life in postsurgical hypoparathyroidism: a case\u2013control study","volume":"45","author":"Mazoni","year":"2022","journal-title":"J Endocrinol Invest."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2018.07.009","article-title":"Hypoparathyroidism and the kidney","volume":"47","author":"Peacock","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B21","doi-asserted-by":"publisher","first-page":"17055","DOI":"10.1038\/nrdp.2017.55","article-title":"Hypoparathyroidism","volume":"3","author":"Mannstadt","year":"2017","journal-title":"Nat Rev Dis Prim."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1800213","article-title":"Hypoparathyroidism","volume":"380","author":"Gafni","year":"2019","journal-title":"Solomon CG editor. N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1159\/000491042","article-title":"Hypoparathyroidism","author":"Hakami","year":"2019","journal-title":"In: Front Hormone Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2257","article-title":"The impact of hypoparathyroidism treatment on the kidney in children: long-term retrospective follow-up study","volume":"100","author":"Levy","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13895","article-title":"Increased mortality and morbidity in patients with chronic hypoparathyroidism: A population-based study","volume":"90","author":"Vadiveloo","year":"2019","journal-title":"Clin Endocrinol (Oxf)."},{"key":"B26","volume-title":"Guidelines for ATC classification and DDD assignment 2020","year":"2018"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5893.643","article-title":"Interpretation of serum calcium in patients with abnormal serum proteins","volume":"4","author":"Payne","year":"1973","journal-title":"BMJ."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-15-0628","article-title":"European Society of Endocrinology clinical guideline: Treatment of chronic hypoparathyroidism in adults","volume":"173","author":"Bollerslev","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2747","article-title":"Ultrasound is superior to computed tomography for assessment of medullary nephrocalcinosis in hypoparathyroidism","volume":"98","author":"Boyce","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/ije\/dyp394","article-title":"Cohort profile: the study of health in pomerania","volume":"40","author":"Volzke","year":"2011","journal-title":"Int J Epidemiol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyac034","article-title":"Cohort profile update: the study of health in pomerania (SHIP)","volume":"51","author":"V\u00f6lzke","year":"2022","journal-title":"Int J Epidemiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5334\/ojb.64","article-title":"The integrated research biobank of the university medicine greifswald","volume":"7","author":"Winter","year":"2020","journal-title":"Open J Bioresour."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.03.035","article-title":"Serum magnesium, phosphorus, and calcium levels and subclinical calcific aortic valve disease: A population-based study","volume":"273","author":"Hisamatsu","year":"2018","journal-title":"Atherosclerosis."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2017.12.001","article-title":"Magnesium as a calcification inhibitor","volume":"25","author":"H\u00e9naut","year":"2018","journal-title":"Adv Chronic Kidney Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1159\/000276665","article-title":"Magnesium in chronic kidney disease: Challenges and opportunities","volume":"29","author":"Kanbay","year":"2010","journal-title":"Blood Purif."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.800119","article-title":"The Russian registry of chronic hypoparathyroidism","volume":"13","author":"Kovaleva","year":"2022","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B41","first-page":"73","article-title":"Greedy methods","volume-title":"Handbook of approximation algorithms and metaheuristics","author":"Bergstralh","year":"2007"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00923","article-title":"Predictors of renal function and calcifications in primary hyperparathyroidism: A nested case-control study","volume":"103","author":"Ejlsmark-Svensson","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2016.12.007","article-title":"Urinary calcium excretion and risk of chronic kidney disease in the general population","volume":"2","author":"Taylor","year":"2017","journal-title":"Kidney Int Rep"},{"key":"B44","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.3390\/jcm9124133","article-title":"Reduced kidney function and relative hypocalciuria\u2014Observational, cross-sectional, population-based data","volume":"9","author":"Cirillo","year":"2020","journal-title":"J Clin Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-019-1556-y","article-title":"Hyperphosphatemia and risks of acute kidney injury, end-stage renal disease, and mortality in hospitalized patients","volume":"20","author":"Moon","year":"2019","journal-title":"BMC Nephrol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41100-017-0142-7","article-title":"Cardiovascular disease, mortality, and magnesium in chronic kidney disease: growing interest in magnesium-related interventions","volume":"4","author":"Ikee","year":"2018","journal-title":"Ren Replace Ther"},{"key":"B47","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/MNH.0b013e32832c2264","article-title":"Parathyroid hormone signaling in bone and kidney","volume":"18","author":"Lee","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0430","article-title":"MECHANISMS IN ENDOCRINOLOGY: Kidney involvement in patients with primary hyperparathyroidism: an update on clinical and molecular aspects","volume":"176","author":"Verdelli","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0244162","article-title":"Acute and long-term kidney function after parathyroidectomy for primary hyperparathyroidism","volume":"15","author":"Belli","year":"2020","journal-title":"PloS One"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2018.08.007","article-title":"\u00bfMejora la funci\u00f3n renal tras la paratiroidectom\u00eda en el hiperparatirodismo primario","volume":"39","author":"Garc\u00eda-Mart\u00edn","year":"2019","journal-title":"Nefrolog\u00eda"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01369-4","article-title":"Parathyroidectomy slows renal function decline in patients with primary hyperparathyroidism","volume":"44","author":"Liang","year":"2021","journal-title":"J Endocrinol Invest."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2016.11.009","article-title":"Renal dysfunction in primary hyperparathyroidism; effect of Parathyroidectomy: A retrospective Cohort Study","volume":"36","author":"Nair","year":"2016","journal-title":"Int J Surg"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1055\/a-0902-8476","article-title":"Long-term treatment with calcitriol in postsurgical hypoparathyroidism leads to renal function decline","volume":"51","author":"Coudenys","year":"2019","journal-title":"Horm Metab Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1530\/EC-20-0219","article-title":"A registry for patients with chronic hypoparathyroidism in Russian adults","volume":"9","author":"Gronskaia","year":"2020","journal-title":"Endocr Connect."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/s0302-2838(03)00415-9","article-title":"Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs","volume":"44","author":"Hesse","year":"2003","journal-title":"2000. Eur Urol."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.03.052","article-title":"Prevalence of kidney stones in the United States","volume":"62","author":"Scales","year":"2012","journal-title":"Eur Urol."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01649-2","article-title":"Risk of nephrolithiasis and nephrocalcinosis in patients with chronic hypoparathyroidism: A retrospective cohort study","volume":"38","author":"Ketteler","year":"2021","journal-title":"Adv Ther"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.14341\/omet12729","article-title":"Daily calcium profile in diagnosis of hypo- And hypercalcemia in patients with chronic hypoparathyroidism","volume":"18","author":"Kovaleva","year":"2021","journal-title":"Clin Case series. Obe Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1244647\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T06:31:17Z","timestamp":1698993077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1244647\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":58,"alternative-id":["10.3389\/fendo.2023.1244647"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1244647","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"article-number":"1244647"}}